A pipeline rich in possibilities

Our portfolio of FTD and ALS gene therapies combine our neuroanatomy-led approach with proprietary AAV gene supplementation and silencing platforms. We are focused on targeted and precise drug delivery and dosing for maximal biodistribution to the brain and spinal cord with a favorable safety profile. We believe delivery to be the gamechanger in overcoming challenges with existing treatment pathways.

“The work we are doing is so important but also challenging. To solve these challenges, teamwork is essential. We work together, united as one strong team, to help address challenges that arise along the way so we can create innovative medicines to treat people with life-threatening disorders.”

John Isaac, PhD

Chief Scientific Officer

John Isaac, PhD

Chief Scientific Officer

Our Science

Find out more about how we are progressing innovative gene therapies to treat neurodegenerative disease.


Learn more about our mission to transform lives and our industry-leading team


Find out more about how we are progressing innovative gene therapies to potentially treat neurodegenerative disease. 


When you join AviadoBio, you join more than just a company, you join a dedicated team with a clear mission



We’d love to hear from you. If you have an enquiry about our gene therapies, delivery systems or clinical trials please contact us using the details here